/
•
•
The draft prospectus of the nine-year-old health tech company is about a stagnant business and a brutal sector.

Editor's note: Two weeks ago, home healthcare company Portea filed its draft initial public offering papers. The company, founded and run by serial entrepreneur couple K. Ganesh and Meena Ganesh in 2013, is the second health technology startup to attempt a public listing in the past year; the other one is online pharmacy PharmEasy, which filed a draft red herring prospectus late last year but hasn’t gone ahead with an IPO yet. From the series of startups backed by the Ganesh couple—including BigBasket, BlueStone and HomeLane—Portea is in fact the first to have filed for an IPO. And it is a fascinating one, to say the least. Portea, incorporated as Healthvista Ltd, is an out-of-hospital healthcare company. Its primary proposition is home care: primary, geriatric, palliative, post-operative, intensive and even mother and baby care. That’s about 60% of its revenue from operations. A good 20% comes from procuring pharmaceuticals from companies and selling them to its patients at a margin. The rest is from the sale and rental of medical equipment. In its draft red herring prospectus, Portea says it is the …

With competition in the segment intensifying, the chief business development officer of India’s largest exchange unpacks the bourse’s strategy going forward.
The home services startup has had a disastrous quarter. It has sunk into losses largely on the back of burning its precious cash to chase the instant domestic help business.
India is ramping up focus on defence drones, and the decade-old startup wants public money to seize the opportunity. But the track record of listed peers offers a cautionary tale.